According to reports, Cantor Fitzgerald CEO Howard Lutnick is now in the running to become President-elect Trump's Treasury ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.73% of ...

Cantor Fitzgerald CEO and President-elect Donald Trump’s transition co-chair, Howard Lutnick, is said to be "campaigning hard ...

Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...

Cantor Fitzgerald tells investors that MariTide’s Phase 1 data includes “a big surprise” as the supplemental appendix file ...

Small caps’ (NYSEARCA:IWM), (SP600) outperformance should continue into the year-end, according to Eric Johnston, senior managing director at Cantor Fitzgerald, in a bi-weekly report.

Cantor Fitzgerald analyst K. Kluska now expects that the biopharmaceutical company will earn ($6.11) per share for the year, up from their previous estimate of ($6.21).

Meeting to be held in Zurich and London on November 19-21 hosted by Cantor Fitzgerald. Published first on TheFly – the ultimate source ...

Cantor Fitzgerald Large Cap Focused Fund earns an Above Average Process Pillar rating. The leading factor in the rating is the parent firm's five-year risk-adjusted success ratio of 100%.

Amgen (NASDAQ:AMGN) shares fell in the evening hours on Tuesday after Cantor Fitzgerald argued that a potential loss of bone ...